...according to today’s PR (#msg-75150121), M402 has started a phase-1/2 trial in pancreatic cancer.
Is a proof-of-concept trial (which I understand this to be) something sanctioned/controlled/required by the FDA, or is it simply an investigative procedure for the company to decide whether or not to move forward?